G-protein-coupled receptor kinase interacting protein-1 is required for pulmonary vascular development

Circulation

Volumn 119, Issue 11, 2009, Pages 1524-1532

  Pang, Jinjiang ^a   Hoefen, Ryan ^a   Pryhuber, Gloria S ^a   Wang, Jing ^a   Yin, Guoyong ^a   White, R James ^a   Xu, Xiangbin ^a   O'Dell, Michael R ^a   Mohan, Amy ^a   Michaloski, Heidi ^a   Massett, Michael P ^a   Yan, Chen ^a   Berk, Bradford C ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Endothelial cell; G protein coupled receptor kinase interactor 1; Mouse; PLC gamma

Indexed keywords

ANGIOTENSIN II; G PROTEIN COUPLED RECEPTOR KINASE INTERACTING PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C GAMMA; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; CELL CYCLE PROTEIN; DNA; GIT1 PROTEIN, MOUSE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IN VIVO STUDY; KNOCKOUT MOUSE; LUNG; LUNG BLOOD VESSEL; LUNG DEVELOPMENT; MOUSE; NONHUMAN; PATHOLOGY; PERINATAL MORTALITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL DIVISION; CONGENITAL MALFORMATION; CYTOLOGY; GENETICS; LUNG ALVEOLUS; LUNG CIRCULATION; METABOLISM; MOUSE MUTANT; NEWBORN; PHOSPHORYLATION; PHYSIOLOGY; PULMONARY ARTERY; PULMONARY VEIN; SIGNAL TRANSDUCTION; SURVIVAL RATE; VASCULARIZATION;

ANIMALS; ANIMALS, NEWBORN; CELL CYCLE PROTEINS; CELL DIVISION; CELLS, CULTURED; DNA; ENDOTHELIAL CELLS; GTPASE-ACTIVATING PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PULMONARY ALVEOLI; PULMONARY ARTERY; PULMONARY CIRCULATION; PULMONARY VEINS; SIGNAL TRANSDUCTION; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 64949196619     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.823997     Document Type: Article

References (31)

1. Premont RT, Claing A, Vitale N, Freeman JL, Pitcher JA, Patton WA, Moss J, Vaughan M, Lefkowitz RJ. beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosy- lation factor GTPase-activating protein. Proc Natl Acad Sci USA. 1998; 95:14082-14087.
2. Premont RT, Claing A, Vitale N, Perry SJ, Lefkowitz RJ. The GIT family of ADP-ribosylation factor GTPase-activating proteins: functional diversity of GIT2 through alternative splicing. J Biol Chem. 2000;275: 22373-22380.
3. Schmalzigaug R, Phee H, Davidson CE, Weiss A, Premont RT. Differential expression of the ARF GAP genes GIT1 and GIT2 in mouse tissues. J Histochem Cytochem. 2007;55:1039-1048.
4. Brown MC, West KA, Turner CE. Paxillin-dependent paxillin kinase linker and p21-activated kinase localization to focal adhesions involves a multistep activation pathway. Mol Biol Cell. 2002;13:1550-1565.
5. Hoefen RJ, Berk BC. The multifunctional GIT family of proteins. J Cell Sci. 2006;119:1469-1475.
6. Yin G, Haendeler J, Yan C, Berk BC. GIT1 functions as a scaffold for MEK1-extracellular signal-regulated kinase 1 and 2 activation by angio- tensin II and epidermal growth factor. Mol Cell Biol. 2004;24:875-885.
7. Mazaki Y, Hashimoto S, Tsujimura T, Morishige M, Hashimoto A, Aritake K, Yamada A, Nam JM, Kiyonari H, Nakao K, Sabe H. Neu- trophil direction sensing and superoxide production linked by the GTPase-activating protein GIT2. Nat Immunol. 2006;7:724-731.
8. Carmeliet P, Moons L, Dewerchin M, Mackman N, Luther T, Breier G, Ploplis V, Muller M, Nagy A, Plow E, Gerard R, Edgington T, Risau W, Collen D. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system. Ann N Y Acad Sci.1997;811:191-206.
9. Jorgensen SM, Demirkaya O, Ritman EL. Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with x-ray micro-CT. Am J Physiol. 1998;275:H1103-H1114.
10. Jin ZG, Wong C, Wu J, Berk BC. Flow shear stress stimulates Gab1 tyrosine phosphorylation to mediate protein kinase B and endothelial nitric-oxide synthase activation in endothelial cells. J Biol Chem. 2005;280:12305-12309.
11. Arkin IT, Xu H, Jensen MO, Arbely E, Bennett ER, Bowers KJ, Chow E, Dror RO, Eastwood MP, Flitman-Tene R, Gregersen BA, Klepeis JL, Kolossvary I, Shan Y, Shaw DE. Mechanism of Na+/H+ antiporting. Science. 2007;317:799-803.
12. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol. 2002;283:L555-L562.
13. Galambos C, Ng YS, Ali A, Noguchi A, Lovejoy S, D'Amore PA, DeMello DE. Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. Am J Respir Cell Mol Biol. 2002;27:194-203.
14. Liao HJ, Kume T, McKay C, Xu MJ, Ihle JN, Carpenter G. Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice. J Biol Chem. 2002;277:9335-9341.
15. Takahashi T, Yamaguchi S, Chida K, Shibuya M. A single autophos- phorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.EMBO J. 2001;20:2768-2778.
16. Sakurai Y, Ohgimoto K, Kataoka Y, Yoshida N, Shibuya M. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc Natl Acad Sci U SA. 2005;102:1076-1081.
17. Durmowicz AG, Stenmark KR. Mechanisms of structural remodeling in chronic pulmonary hypertension. Pediatr Rev. 1999;20:e91-e102.
18. Stenmark KR, Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol. 1997;59:89-144.
19. Stenmark KR, Balasubramaniam V. Angiogenic therapy for bronchopul- monary dysplasia: rationale and promise. Circulation. 2005;112:2383-2385.
20. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS,Powell-Braxton L, Hillan KJ, Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature.1996;380:439-442.
21. deMello DE, Sawyer D, Galvin N, Reid LM. Early fetal development of lung vasculature. Am J Respir Cell Mol Biol. 1997;16:568-581.
22. Hislop AA. Airway and blood vessel interaction during lung development. J Anat. 2002;201:325-334.
23. Hislop A. Developmental biology of the pulmonary circulation. Paediatr espir Rev. 2005;6:35-43.
24. Frey U, Hislop A, Silverman M. Branching properties of the pulmonary arterial tree during pre- and postnatal development. Respir Physiol Neu-robiol. 2004;139:179-189.
25. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999;18:3964-3972.
26. Haendeler J, Yin G, Hojo Y, Saito Y, Melaragno M, Yan C, Sharma VK, Heller M, Aebersold R, Berk BC. GIT1 mediates Src-dependent activation of phospholipase Cgamma by angiotensin II and epidermal growth factor. J Biol Chem. 2003;278:49936-49944.
27. Yin G, Zheng Q, Yan C, Berk BC. GIT1 is a scaffold for ERK1/2 activation in focal adhesions. J Biol Chem. 2005;280:27705-27712.
28. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, Huyck H. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol. 2002;282:L811-L823.
29. Chess PR, D'Angio CT, Pryhuber GS, Maniscalco WM. Pathogenesis of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:171-178.
30. D'Angio CT, Maniscalco WM. Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies. Paediatr Drugs. 2004;6:303-330.
31. Rabah R, Poulik JM. Congenital alveolar capillary dysplasia with misalignment of pulmonary veins associated with hypoplastic left heart syndrome. Pediatr Dev Pathol. 2001;4:167-174.